Exane Derivatives’s FMC FMC Stock Holding History

Exane Derivatives’s Portfolio FMC Stock Details FMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.18K	Sell	11 -5,011	-100%	-$612K	﹤0.01%	493
2022 Q1	$661K	Sell	5,022 -1,657	-25%	-$195K	0.19%	144
2021 Q4	$734K	Buy	6,679 +1,541	+30%	+$155K	0.18%	128
2021 Q3	$470K	Buy	5,138 +5,133	+102,660%	+$507K	0.11%	200
2021 Q2	$535	Hold	5	–	–	﹤0.01%	936
2021 Q1	$553	Hold	5	–	–	﹤0.01%	788
2020 Q4	$575	Sell	5 -18	-78%	-$2K	﹤0.01%	728
2020 Q3	$2.44K	Sell	23 -423	-95%	-$45.3K	﹤0.01%	548
2020 Q2	$44.4K	Sell	446 -6,002	-93%	-$554K	0.01%	361
2020 Q1	$527K	Sell	6,448 -905	-12%	-$84K	0.15%	120
2019 Q4	$724K	Sell	7,353 -878	-11%	-$81.6K	0.13%	121
2019 Q3	$722K	Sell	8,231 -971	-11%	-$83.3K	0.13%	128
2019 Q2	$763K	Buy	9,202 +8,005	+669%	+$628K	0.13%	124
2019 Q1	$91.9K	Sell	1,197 -657	-35%	-$48.2K	0.02%	304
2018 Q4	$119K	Sell	1,854 -346	-16%	-$24.3K	0.02%	303
2018 Q3	$166K	Buy	2,200 +391	+22%	+$29.5K	0.03%	264
2018 Q2	$141K	Buy	+1,809	New	+$134K	0.02%	292

Other funds holding FMC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Exane Derivatives's FMC Position: Q2 2022 in Review

Exane Derivatives reduced its FMC (FMC) stake by 100% in Q2 2022, selling an estimated $612K and leaving 11 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #493.

Exane Derivatives first reported a position in FMC in Q2 2018 and has held it in 17 quarters since. The position peaked at $763K in Q2 2019. 625 funds tracked by Wall St. Rank hold FMC as of Q2 2022.

Exane Derivatives held 11 shares of FMC worth $1.18K as of Q2 2022.
Exane Derivatives sold 5,011 FMC shares in Q2 2022, an estimated $612K.
FMC made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #493 holding.
Exane Derivatives first reported a position in FMC in Q2 2018 and has held it in 17 quarters since.
Exane Derivatives's FMC position peaked at $763K in Q2 2019.
625 funds tracked by Wall St. Rank held FMC as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.